Table 3.
Age-specific average annual percent change further stratified by cancer stage and screening process.
| Variables | All | Squamous Cell Carcinoma | Adenocarcinoma | ||||||
|---|---|---|---|---|---|---|---|---|---|
| N | AAPC | 95% CI | N | AAPC | 95% CI | N | AAPC | 95% CI | |
| Early-stage cancer | |||||||||
| Via cancer screening | |||||||||
| Overall | 924 | 11.6 | −3.8, 29.5 | 853 | 12.5 | −3.3, 31.0 | 59 | 6.8 | −21.0, 44.3 |
| Age <50 | 729 | 15.0 | −3.9, 37.6 | 677 | 15.7 | −3.5, 38.8 | 45 | 12.4 | −27.0, 73.0 |
| Age ≥50 | 195 | 3.3 | −0.3, 7.0 | 176 | 4.4 | −0.3, 9.2 | 14 | 0.4 | −29.6, 43.2 |
| Not-via cancer screening | |||||||||
| Overall | 798 | 13.6 | 4.9, 23.1 | 712 | 15.7 | 6.9, 25.3 | 74 | −2.1 | −23.4, 25.2 |
| Age <50 | 623 | 16.5 | 8.7, 25.0 | 571 | 18.0 | 10.6, 26.0 | 43 | −0.1 | −30.1, 42.7 |
| Age ≥50 | 175 | 7.6 | −11.1, 30.3 | 141 | 11.2 | −10.5, 38.2 | 31 | −3.1 | −23.2, 22.1 |
| Advanced-stage cancer | |||||||||
| Via cancer screening | |||||||||
| Overall | 63 | −16.5 | −34.0, 5.6 | 49 | −14.8 | −27.9, 0.6 | 11 | −23.7 | −48.4, 12.8 |
| Age <50 | 26 | −2.0 | −27.1, 31.9 | 21 | 4.3 | −26.5, 48.1 | 4 | n/a | |
| Age ≥50 | 37 | −26.2 | −44.5, −1.9 | 28 | −27.9 | −48.6, 1.1 | 7 | −20.2 | −35.3, −1.6 |
| Not-via cancer screening | |||||||||
| Overall | 325 | −3.9 | −20.0, 15.5 | 247 | −3.5 | −22.2, 19.6 | 57 | −6.3 | −27.7, 21.3 |
| Age <50 | 96 | −2.9 | −23.1, 22.7 | 68 | −1.6 | −29.9, 38.0 | 19 | −2.8 | −47.1, 78.9 |
| Age ≥50 | 229 | −4.6 | −20.4, 14.4 | 179 | −4.3 | −20.6, 15.5 | 38 | −3.6 | −34.2, 41.3 |
Abbreviation: AAPC, average annual percent change; CI, confidence interval; N, number.